◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › T › TDOC

Teladoc Inc (TDOC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · HEALTH INFORMATION SERVICES · DATA UPDATED 2026-09-17

Teladoc Inc (TDOC) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in New York, United States with about 4,648 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, TDOC reported $2.5B in revenue and ($200M) in net income.

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments.

Interactive charts & full statements → Open the TDOC valuation workbench →

TDOC Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Total Revenue	$2.5B	$2.5B	$2.6B	$2.6B	$2.4B	$2.0B	$1.1B	$553M	$418M	$233M	$123M	$77M	$44M	$20M
Gross Profit	$1.8B	$1.8B	$1.8B	$1.8B	$1.7B	$1.4B	$703M	$369M	$289M	$172M	$91M	$56M	$34M	$16M
Gross Margin %	73.5%	69.5%	70.8%	70.8%	69.1%	68.0%	64.3%	66.7%	69.2%	73.6%	74.0%	72.8%	77.2%	79.0%
Operating Income (EBIT)	($174M)	($263M)	($1.0B)	($249M)	($13.2B)	($266M)	($506M)	($80M)	($71M)	($75M)	($63M)	($56M)	($15M)	($6M)
Operating Margin %	-7.0%	-10.4%	-39.7%	-9.6%	-548.4%	-13.1%	-46.3%	-14.5%	-17.0%	-32.3%	-50.9%	-72.1%	-34.8%	-29.5%
Net Income	($177M)	($200M)	($1.0B)	($220M)	($13.7B)	($429M)	($485M)	($99M)	($97M)	($107M)	($74M)	($58M)	($17M)	($6M)
Net Margin %	-7.1%	-7.9%	-39.0%	-8.5%	-567.5%	-21.1%	-44.4%	-17.9%	-23.2%	-45.8%	-60.3%	-75.0%	-39.1%	-30.2%
EBITDA	($70M)	$147M	$32M	$44M	($13.5B)	($31M)	($354M)	($35M)	($30M)	($43M)	($44M)	($47M)	($12M)	($5M)
Earnings Per Share (EPS)	$-1.00	$-1.14	$-5.87	$-1.34	$-84.60	$-2.73	$-5.36	$-1.38	$-1.47	$-1.93	$-1.75	$-2.91	$-0.62	$-0.22
Shares Outstanding (M)	180M	176M	171M	165M	161M	157M	91M	72M	66M	55M	42M	20M	28M	28M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TDOC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$607M	$614M	$642M	$626M	$632M	$629M	$640M	$641M
Gross Profit	$622M	$324M	$445M	$439M	$441M	$433M	$452M	$461M
Gross Margin %	102.5%	52.8%	69.3%	70.1%	69.8%	68.7%	70.5%	71.9%
Operating Income (EBIT)	($37M)	($49M)	($36M)	($52M)	($54M)	($121M)	($48M)	($44M)
Operating Margin %	-6.1%	-7.9%	-5.6%	-8.3%	-8.6%	-19.2%	-7.5%	-6.9%
Net Income	($39M)	($64M)	($25M)	($50M)	($33M)	($93M)	($48M)	($33M)
Net Margin %	-6.4%	-10.4%	-3.9%	-7.9%	-5.2%	-14.8%	-7.6%	-5.2%
EBITDA	($125M)	$39M	$51M	($35M)	$3M	($9M)	$12M	$13M
Earnings Per Share (EPS)	$-0.22	$-0.36	$-0.14	$-0.28	$-0.19	$-0.53	$-0.28	$-0.19
Shares Outstanding (M)	180M	179M	176M	176M	176M	174M	173M	171M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TDOC Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Cash from Operations (CFO)	$261M	$294M	$294M	$350M	$189M	$194M	($54M)	$30M	($5M)	($34M)	($52M)	($47M)	($11M)	($6M)
Capital Expenditures (CapEx)	$37M	$9M	$11M	$156M	$16M	$9M	$26M	$11M	$8M	$6M	$3M	$8M	$2M	$1M
Free Cash Flow (FCF)	$225M	$285M	$283M	$194M	$173M	$185M	($80M)	$19M	($13M)	($40M)	($55M)	($55M)	($13M)	($7M)
FCF Margin %	9.0%	11.3%	11.0%	7.4%	7.2%	9.1%	-7.3%	3.4%	-3.2%	-17.1%	-44.8%	-71.1%	-30.1%	-36.9%
Dividends Paid	—	—	—	—	—	—	$32M	$33M	—	$0M	$0M	$0M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TDOC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$65M	$10M	$88M	$99M	$91M	$16M	$86M	$110M
Capital Expenditures (CapEx)	$1M	$2M	$3M	$31M	$1M	$32M	$30M	$31M
Free Cash Flow (FCF)	$64M	$8M	$85M	$68M	$90M	($16M)	$56M	$79M
FCF Margin %	10.5%	1.3%	13.2%	10.8%	14.3%	-2.5%	8.8%	12.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TDOC Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Total Assets	$2.8B	$3.1B	$3.5B	$4.4B	$4.7B	$17.7B	$17.8B	$1.6B	$1.5B	$824M	$304M	$230M	$92M	$27M
Cash & Cash Equivalents	$774M	$781M	$1.3B	$1.1B	$918M	$893M	$733M	$514M	$424M	$43M	$50M	$55M	$46M	$3M
Total Liabilities	$1.4B	$1.7B	$2.0B	$2.1B	$2.4B	$1.7B	$1.9B	$589M	$516M	$265M	$73M	$51M	$39M	$8M
Total Debt (Short + Long-Term)	$1.0B	$1.0B	$1.6B	$1.5B	$1.5B	$1.2B	$1.4B	$445M	$417M	$235M	$44M	$26M	$26M	$3M
Total Shareholders' Equity	$1.3B	$1.4B	$1.5B	$2.3B	$2.3B	$16.0B	$15.9B	$1.0B	$1.0B	$559M	$231M	$179M	$53M	$19M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TDOC viewer.

Other Companies in HEALTH INFORMATION SERVICES

OMCL · Omnicell Inc — $1 billion
CERT · Certara Inc — $1 billion
OMDA · Omada Health, Inc. Common Stock — $1 billion
GDRX · Goodrx Holdings Inc — $1 billion
HSTM · HealthStream Inc — $894 million
TEM · Tempus AI, Inc. Class A Common Stock — $14 billion
BTSG · BrightSpring Health Services, Inc. Common Stock — $11 billion
TXG · 10X Genomics Inc — $10 billion

← TDIV All “T” companies TDOG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.